Share-based Compensation (Tables)

3 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Summary of share-based compensation expense for options

The following table summarizes the share-based compensation expense for SSARs, restricted and performance grants included in the condensed consolidated statements of operations:

	Three Months Ended June 30,
(In thousands)	2022		2021
Product development		1,521		2,065
Sales and marketing		275		331
General and administrative		692		1,225
Total share-based compensation expense		2,488		3,621

Activity related SSARs award

The following table summarizes the activity during the three months ended June 30, 2022 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2022		2,172,939		$	24.02
Granted		—			—
Exercised		(114,360	)		16.04
Forfeited		(19,171	)		20.02
Expired		—			—
Outstanding at June 30, 2022		2,039,408		$	24.51		4.2	$	46,419
Exercisable at June 30, 2022		1,528,171		$	24.50		4.1	$	34,802
Vested and expected to vest at June 30, 2022		2,039,408		$	24.51		4.2	$	46,419

Activity related to restricted shares awarded by the Company

The following table summarizes the activity during the three months ended June 30, 2022 for restricted shares awarded under the 2020 and 2016 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2022		147,973		$	43.56
Granted		252,707			42.91
Vested		(7,434	)		36.68
Forfeited		(2,885	)		45.76
Outstanding at June 30, 2022		390,361		$	43.25